Bassler Bonnie L 4

What Happened Bonnie L. Bassler, a director of Royalty Pharma plc (RPRX), received an award of 4,545 restricted stock units (RSUs) reported as an acquisition on 2026-06-05. The Form 4 records the transaction price as $0.00 (typical for equity awards); no cash changed hands on grant.

Key Details

• Transaction date: 2026-06-05; Form 4 filed: 2026-06-08 (timely filing).
• Transaction type/code: Award/Grant (A).
• Shares/units granted: 4,545 RSUs; price reported: $0.00; reported value: $0 on grant.
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Footnote: Award is under the Issuer's 2020 Independent Director Equity Incentive Plan and generally vests 100% on the earlier of (i) one-year anniversary of the grant or (ii) the annual meeting in the next calendar year, subject to plan/award terms (see footnote F1).
• No indication of a 10b5-1 plan, sale, or option exercise in this filing.

Context RSU grants to directors are common compensation and are recorded at $0 on grant because no purchase occurred; value will be realized only upon vesting and any subsequent sale. Such awards signal compensation alignment with shareholders but are not the same as an insider buying stock with personal funds.